Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease.

Abstract

The current study was undertaken to elucidate a possible neuroprotective role of dehydroepiandrosterone (DHEA) against the development of Alzheimer's disease in experimental rat model. Alzheimer's disease was produced in young female ovariectomized rats by intraperitoneal administration of AlCl(3) (4.2 mg/kg body weight) daily for 12 weeks. Half of these animals also received orally DHEA (250 mg/kg body weight, three times weekly) for 18 weeks. Control groups of animals received either DHAE alone, or no DHEA, or were not ovariectomized. After such treatment the animals were analyzed for oxidative stress biomarkers such as hydrogen peroxide, nitric oxide and malondialdehyde, total antioxidant capacity, reduced glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase and catalase activities, antiapoptotic marker Bcl-2 and brain derived neurotrophic factor. Also brain cholinergic markers (acetylcholinesterase and acetylcholine) were determined. The results revealed significant increase in oxidative stress parameters associated with significant decrease in the antioxidant enzyme activities in Al-intoxicated ovariectomized rats. Significant depletion in brain Bcl-2 and brain-derived neurotrophic factor levels were also detected. Moreover, significant elevations in brain acetylcholinesterase activity accompanied with significant reduction in acetylcholine level were recorded. Significant amelioration in all investigated parameters was detected as a result of treatment of Al-intoxicated ovariectomized rats with DHEA. These results were confirmed by histological examination of brain sections. These results clearly indicate a neuroprotective effect of DHEA against Alzheimer's disease.

Synthesis of novel steroidal curcumin derivatives as anti-Alzheimer’s disease candidates: Evidences-based on in vivo study

“…2I). These results are in agreement with Morinaga et al [66] who demonstrated that steroids exerts antiamyloidogenic activity, and Aly et al [67] who observed that dehydroepiandrosterone (DHEA) can protect against Ab toxicity in hippocampal cells.…”

Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats

“…Aly et al 32 reported that BDNF levels were significantly reduced in rat model of AD induced by intraperitoneal administration of aluminum chloride (AlCl 3 ), while Kirk et al 33 reported that changes in serum level of BDNF might be contributing to shrinkage of the hippocampus that is associated with age related memory decline in late adulthood. Moreover, it was found that a novel polymorphism in BDNF gene was associated with late onset AD.…”

Protective effect of a calcium channel blocker “diltiazem” on aluminum chloride-induced dementia in mice

“…Aluminum is not very toxic at normal levels, but its chronic exposure may lead to speech disturbance, dyspraxia, tremors, psychosis, partial paralysis, loss of memory and cognition, and ultimately death (Buraimoh et al 2012). Aluminum accumulates in the hippocampus in the forms of amyloid beta plaques and neurofibrillary tangles which underlie the pathogenesis of AD (Aly et al 2011). Accumulation of aluminum results in reactive oxygen species (ROS) formation which depletes normal antioxidant defense mechanism followed by oxidative stress and lipid peroxidation leading to amyloid deposition (Oguz et al 2012).…”